Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome

Authors: Paula Freitas, Davide Carvalho, Ana Cristina Santos, António José Madureira, Esteban Martinez, Jorge Pereira, António Sarmento, José Luís Medina

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Lipodystrophies are characterized by adipose tissue redistribution, insulin resistance (IR) and metabolic complications. Adipokines and hormones related to body composition may play an important role linking these alterations. Our aim was to evaluate adipocyte-derived hormones (adiponectin, leptin, resistin, TNF-α, PAI-1) and ghrelin plasma levels and their relationship with IR in HIV-infected patients according to the presence of lipodystrophy and fat redistribution.

Methods

Anthropometric and metabolic parameters, HOMA-IR, body composition by DXA and CT, and adipokines were evaluated in 217 HIV-infected patients on cART and 74 controls. Fat mass ratio defined lipodystrophy (L-FMR) was defined as the ratio of the percentage of the trunk fat mass to the percentage of the lower limb fat mass by DXA. Patient’s fat redistribution was classified into 4 different groups according the presence or absence of either clinical lipoatrophy or abdominal prominence: no lipodystrophy, isolated central fat accumulation (ICFA), isolated lipoatrophy and mixed forms (MXF). The associations between adipokines levels and anthropometric, metabolic and body composition were estimated by Spearman correlation.

Results

Leptin levels were lower in patients with FMR-L and isolated lipoatrophy, and higher in those with ICFA and MXF. Positive correlations were found between leptin and body fat (total, trunk, leg, arm fat evaluated by DXA, and total, visceral (VAT), subcutaneous adipose tissue (SAT), and VAT/SAT ratio evaluated by CT) regardless of FMR-L, and with HOMA-IR only in patients with FMR-L. Adiponectin correlated negatively with VAT, and its mean levels were lower in patients with ICFA and higher in those with no lipodystrophy. Resistin was not correlated with adipose tissue but positively correlated with HOMA-IR in FMR-L patients. PAI-1 levels were higher in MXF-patients and their levels were positively correlated with VAT in those with FMR-L. Ghrelin was higher in HIV-infected patients than controls despite BMI-matching.

Conclusion

The overall body fat reduction in HIV lipoatrophy was associated with low leptin plasma levels, and visceral fat accumulation was mainly associated with decreased plasma levels of adiponectin.
Literature
2.
go back to reference Veloso S, Escote X, Ceperuelo-Mallafre V, Lopez-Dupla M, Peraire J, Vilades C, Domingo P, Castro A, Olona M, Sirvent JJ, Leal M, Vendrell J, Richart C, Vidal F: Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy. Cytokine. 2012, 58 (2): 253-260.CrossRefPubMed Veloso S, Escote X, Ceperuelo-Mallafre V, Lopez-Dupla M, Peraire J, Vilades C, Domingo P, Castro A, Olona M, Sirvent JJ, Leal M, Vendrell J, Richart C, Vidal F: Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy. Cytokine. 2012, 58 (2): 253-260.CrossRefPubMed
3.
go back to reference Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006, 64 (4): 355-365. Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006, 64 (4): 355-365.
4.
go back to reference Falasca K, Ucciferri C, Mancino P, Di Iorio A, Vignale F, Pizzigallo E, Vecchiet J: Cystatin C, adipokines and cardiovascular risk in HIV infected patients. Curr HIV Res. 2010, 8 (5): 405-410.CrossRefPubMed Falasca K, Ucciferri C, Mancino P, Di Iorio A, Vignale F, Pizzigallo E, Vecchiet J: Cystatin C, adipokines and cardiovascular risk in HIV infected patients. Curr HIV Res. 2010, 8 (5): 405-410.CrossRefPubMed
5.
go back to reference Koutkia P, Meininger G, Canavan B, Breu J, Grinspoon S: Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. Am J Physiol Endocrinol Metab. 2004, 286 (2): E296-E303.CrossRefPubMed Koutkia P, Meininger G, Canavan B, Breu J, Grinspoon S: Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. Am J Physiol Endocrinol Metab. 2004, 286 (2): E296-E303.CrossRefPubMed
6.
go back to reference Sweeney LL, Brennan AM, Mantzoros CS: The role of adipokines in relation to HIV lipodystrophy. AIDS. 2007, 21 (8): 895-904.CrossRefPubMed Sweeney LL, Brennan AM, Mantzoros CS: The role of adipokines in relation to HIV lipodystrophy. AIDS. 2007, 21 (8): 895-904.CrossRefPubMed
7.
go back to reference Samaras K, Gan SK, Peake PW, Carr A, Campbell LV: Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection. Obesity (Silver Spring). 2009, 17 (1): 53-59.CrossRef Samaras K, Gan SK, Peake PW, Carr A, Campbell LV: Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection. Obesity (Silver Spring). 2009, 17 (1): 53-59.CrossRef
8.
9.
go back to reference CDC: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Recomm Rep. 1993, 41: 1-19. CDC: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Recomm Rep. 1993, 41: 1-19.
10.
go back to reference Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL: Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy. J Clin Densitom. 2010, 13 (2): 197-203.CrossRefPubMed Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL: Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy. J Clin Densitom. 2010, 13 (2): 197-203.CrossRefPubMed
11.
go back to reference Freitas P, Carvalho D, Santos AC, Mesquita J, Correia F, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults. J Endocrinol Investig. 2011, 34 (10): e321-e329. Freitas P, Carvalho D, Santos AC, Mesquita J, Correia F, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults. J Endocrinol Investig. 2011, 34 (10): e321-e329.
12.
go back to reference Freitas P, Carvalho D, Santos AC, Matos MJ, Madureira AJ, Marques R, Martinez E, Sarmento A, Medina JL: Prevalence of obesity and its relationship to clinical lipodystrophy in HIV-infected adults on anti-retroviral therapy. J Endocrinol Investig. 2012, 35 (11): 964-970. Freitas P, Carvalho D, Santos AC, Matos MJ, Madureira AJ, Marques R, Martinez E, Sarmento A, Medina JL: Prevalence of obesity and its relationship to clinical lipodystrophy in HIV-infected adults on anti-retroviral therapy. J Endocrinol Investig. 2012, 35 (11): 964-970.
13.
go back to reference Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011, 11: 246-CrossRefPubMedPubMedCentral Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011, 11: 246-CrossRefPubMedPubMedCentral
14.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lung Blood Institute Joint National Committee on Prevention, Detection Evaluation Treatment of High Blood, Pressure: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2572.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lung Blood Institute Joint National Committee on Prevention, Detection Evaluation Treatment of High Blood, Pressure: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2572.CrossRefPubMed
15.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645.CrossRefPubMed
16.
go back to reference Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J: Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005, 8 (3): 287-292.CrossRefPubMed Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J: Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005, 8 (3): 287-292.CrossRefPubMed
17.
go back to reference van der Kooy K, Seidell JC: Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993, 17 (4): 187-196.PubMed van der Kooy K, Seidell JC: Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993, 17 (4): 187-196.PubMed
18.
go back to reference Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Matsuzawa Y: Abdominal fat: standardized technique for measurement at CT. Radiology. 1999, 211 (1): 283-286.CrossRefPubMed Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Matsuzawa Y: Abdominal fat: standardized technique for measurement at CT. Radiology. 1999, 211 (1): 283-286.CrossRefPubMed
19.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28 (7): 412-419.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28 (7): 412-419.CrossRefPubMed
20.
go back to reference Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85 (7): 2402-2410.CrossRefPubMed Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85 (7): 2402-2410.CrossRefPubMed
21.
go back to reference Grinspoon S: Insulin resistance in the HIV-lipodystrophy syndrome. Trends Endocrinol Metab. 2001, 12 (9): 413-419.CrossRefPubMed Grinspoon S: Insulin resistance in the HIV-lipodystrophy syndrome. Trends Endocrinol Metab. 2001, 12 (9): 413-419.CrossRefPubMed
22.
go back to reference Reitman ML, Arioglu E, Gavrilova O, Taylor SI: Lipoatrophy revisited. Trends Endocrinol Metab. 2000, 11 (10): 410-416.CrossRefPubMed Reitman ML, Arioglu E, Gavrilova O, Taylor SI: Lipoatrophy revisited. Trends Endocrinol Metab. 2000, 11 (10): 410-416.CrossRefPubMed
23.
go back to reference Hegele RA: Insulin resistance in human partial lipodystrophy. Curr Atheroscler Rep. 2000, 2 (5): 397-404.CrossRefPubMed Hegele RA: Insulin resistance in human partial lipodystrophy. Curr Atheroscler Rep. 2000, 2 (5): 397-404.CrossRefPubMed
24.
go back to reference Mynarcik DC, Combs T, McNurlan MA, Scherer PE, Komaroff E, Gelato MC: Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J Acquir Immune Defic Syndr. 2002, 31 (5): 514-520.CrossRefPubMed Mynarcik DC, Combs T, McNurlan MA, Scherer PE, Komaroff E, Gelato MC: Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J Acquir Immune Defic Syndr. 2002, 31 (5): 514-520.CrossRefPubMed
25.
go back to reference Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J: Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther. 2004, 9 (2): 161-177.PubMed Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J: Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther. 2004, 9 (2): 161-177.PubMed
26.
go back to reference Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334 (5): 292-295.CrossRefPubMed Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334 (5): 292-295.CrossRefPubMed
27.
go back to reference Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999, 257 (1): 79-83.CrossRefPubMed Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999, 257 (1): 79-83.CrossRefPubMed
28.
go back to reference Vigouroux C, Maachi M, Nguyen TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP: Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS. 2003, 17 (10): 1503-1511.CrossRefPubMed Vigouroux C, Maachi M, Nguyen TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP: Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS. 2003, 17 (10): 1503-1511.CrossRefPubMed
29.
go back to reference Haque WA, Shimomura I, Matsuzawa Y, Garg A: Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002, 87 (5): 2395-CrossRefPubMed Haque WA, Shimomura I, Matsuzawa Y, Garg A: Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002, 87 (5): 2395-CrossRefPubMed
30.
go back to reference Kosmiski LA, Bacchetti P, Kotler DP, Heymsfield SB, Lewis CE, Shlipak MG, Scherzer R, Grunfeld C: Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab. 2008, 93 (1): 216-224.CrossRefPubMed Kosmiski LA, Bacchetti P, Kotler DP, Heymsfield SB, Lewis CE, Shlipak MG, Scherzer R, Grunfeld C: Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab. 2008, 93 (1): 216-224.CrossRefPubMed
31.
go back to reference Martini G, Valenti R, Giovani S, Campagna S, Franci B, Nuti R: Leptin and body composition in healthy postmenopausal women. Panminerva Med. 2001, 43 (3): 149-154.PubMed Martini G, Valenti R, Giovani S, Campagna S, Franci B, Nuti R: Leptin and body composition in healthy postmenopausal women. Panminerva Med. 2001, 43 (3): 149-154.PubMed
32.
go back to reference Wunder D, Bersinger NA, Fux C, Weber R, Bernasconi E, Cavassini M, Bucher HC, Schiffer V, Schmid P, Furrer H: Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS. 2005, 19 (16): 1837-1842.CrossRefPubMed Wunder D, Bersinger NA, Fux C, Weber R, Bernasconi E, Cavassini M, Bucher HC, Schiffer V, Schmid P, Furrer H: Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS. 2005, 19 (16): 1837-1842.CrossRefPubMed
33.
go back to reference Koutkia P, Canavan B, Breu J, Johnson ML, Depaoli A, Grinspoon SK: Relation of leptin pulse dynamics to fat distribution in HIV-infected patients. Am J Clin Nutr. 2004, 79 (6): 1103-1109.PubMed Koutkia P, Canavan B, Breu J, Johnson ML, Depaoli A, Grinspoon SK: Relation of leptin pulse dynamics to fat distribution in HIV-infected patients. Am J Clin Nutr. 2004, 79 (6): 1103-1109.PubMed
34.
go back to reference Freitas PCD, Santos AC, Xerinda S, Matos MJ, Marques R, Serrão R, Pereira J, Sarmento A, Medina JL: A one year prospective study indicates that HIV patients under antiretroviral therapy worsen lipodystrophy. Arq Bras Endocrinol Metabol. 2008, 52: S945- Freitas PCD, Santos AC, Xerinda S, Matos MJ, Marques R, Serrão R, Pereira J, Sarmento A, Medina JL: A one year prospective study indicates that HIV patients under antiretroviral therapy worsen lipodystrophy. Arq Bras Endocrinol Metabol. 2008, 52: S945-
35.
go back to reference Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A: Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002, 346 (8): 570-578.CrossRefPubMed Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A: Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002, 346 (8): 570-578.CrossRefPubMed
36.
go back to reference Tong Q, Sankale JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab. 2003, 88 (4): 1559-1564.CrossRefPubMed Tong Q, Sankale JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab. 2003, 88 (4): 1559-1564.CrossRefPubMed
37.
go back to reference Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS: Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab. 2003, 88 (2): 627-636.CrossRefPubMed Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS: Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab. 2003, 88 (2): 627-636.CrossRefPubMed
38.
go back to reference Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M: Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003, 58 (1): 22-29.CrossRef Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M: Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003, 58 (1): 22-29.CrossRef
39.
go back to reference Wong SP, Huda M, English P, Bargiotta A, Wilding JP, Johnson A, Corrall R, Pinkney JH: Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. Diabetologia. 2005, 48 (12): 2641-2649.CrossRefPubMed Wong SP, Huda M, English P, Bargiotta A, Wilding JP, Johnson A, Corrall R, Pinkney JH: Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. Diabetologia. 2005, 48 (12): 2641-2649.CrossRefPubMed
40.
go back to reference Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpleby AM, Thomas EL, Bell JD, Dixon AK, Dunne F, Boiani R, Cinti S, Vidal-Puig A, Karpe F, Chatterjee VK, O'Rahilly S: Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 2003, 52 (4): 910-917.CrossRefPubMed Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpleby AM, Thomas EL, Bell JD, Dixon AK, Dunne F, Boiani R, Cinti S, Vidal-Puig A, Karpe F, Chatterjee VK, O'Rahilly S: Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 2003, 52 (4): 910-917.CrossRefPubMed
41.
go back to reference Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R: Adipocyte-derived hormone levels in HIV lipodystrophy. Antivir Ther. 2003, 8 (1): 9-15.PubMed Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R: Adipocyte-derived hormone levels in HIV lipodystrophy. Antivir Ther. 2003, 8 (1): 9-15.PubMed
42.
go back to reference Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC: Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr. 2000, 25 (4): 312-321.CrossRefPubMed Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC: Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr. 2000, 25 (4): 312-321.CrossRefPubMed
43.
go back to reference Estrada V, Martinez-Larrad MT, Gonzalez-Sanchez JL, De Villar NG, Zabena C, Fernandez C, Serrano-Rios M: Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. Metabolism. 2006, 55 (7): 940-945.CrossRefPubMed Estrada V, Martinez-Larrad MT, Gonzalez-Sanchez JL, De Villar NG, Zabena C, Fernandez C, Serrano-Rios M: Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. Metabolism. 2006, 55 (7): 940-945.CrossRefPubMed
44.
go back to reference Chaparro J, Reeds DN, Wen W, Xueping E, Klein S, Semenkovich CF, Bae KT, Quirk EK, Powderly WG, Yarasheski KE, Li E: Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. Metabolism. 2005, 54 (5): 561-567.CrossRefPubMedPubMedCentral Chaparro J, Reeds DN, Wen W, Xueping E, Klein S, Semenkovich CF, Bae KT, Quirk EK, Powderly WG, Yarasheski KE, Li E: Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. Metabolism. 2005, 54 (5): 561-567.CrossRefPubMedPubMedCentral
45.
go back to reference Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003, 149 (4): 331-335.CrossRefPubMed Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003, 149 (4): 331-335.CrossRefPubMed
46.
go back to reference Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003, 88 (10): 4848-4856.CrossRefPubMed Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003, 88 (10): 4848-4856.CrossRefPubMed
47.
go back to reference Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, Park KS: Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004, 89 (1): 150-156.CrossRefPubMed Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, Park KS: Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004, 89 (1): 150-156.CrossRefPubMed
48.
go back to reference Barb D, Wadhwa SG, Kratzsch J, Gavrila A, Chan JL, Williams CJ, Karchmer AW, Mantzoros CS: Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome. J Clin Endocrinol Metab. 2005, 90 (9): 5324-5328.CrossRefPubMed Barb D, Wadhwa SG, Kratzsch J, Gavrila A, Chan JL, Williams CJ, Karchmer AW, Mantzoros CS: Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome. J Clin Endocrinol Metab. 2005, 90 (9): 5324-5328.CrossRefPubMed
49.
go back to reference Escote X, Miranda M, Veloso S, Domingo P, Alonso-Villaverde C, Peraire J, Vilades C, Alba V, Olona M, Castro A, Lopez-Dupla M, Sirvent JJ, Vicente V, Vendrell J, Richart C, Vidal F, and HIV Lipodystrophy Study Group: Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin. J Acquir Immune Defic Syndr. 2011, 57 (1): 16-23.CrossRefPubMed Escote X, Miranda M, Veloso S, Domingo P, Alonso-Villaverde C, Peraire J, Vilades C, Alba V, Olona M, Castro A, Lopez-Dupla M, Sirvent JJ, Vicente V, Vendrell J, Richart C, Vidal F, and HIV Lipodystrophy Study Group: Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin. J Acquir Immune Defic Syndr. 2011, 57 (1): 16-23.CrossRefPubMed
50.
go back to reference Kamin D, Hadigan C, Lehrke M, Mazza S, Lazar MA, Grinspoon S: Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab. 2005, 90 (6): 3423-3426.CrossRefPubMed Kamin D, Hadigan C, Lehrke M, Mazza S, Lazar MA, Grinspoon S: Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab. 2005, 90 (6): 3423-3426.CrossRefPubMed
51.
go back to reference Johnson JA, Albu JB, Engelson ES, Fried SK, Inada Y, Ionescu G, Kotler DP: Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab. 2004, 286 (2): E261-E271.CrossRefPubMed Johnson JA, Albu JB, Engelson ES, Fried SK, Inada Y, Ionescu G, Kotler DP: Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab. 2004, 286 (2): E261-E271.CrossRefPubMed
52.
go back to reference Hauner H: Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005, 64 (2): 163-169.CrossRefPubMed Hauner H: Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005, 64 (2): 163-169.CrossRefPubMed
53.
go back to reference Vidal F, Domingo P, Vilades C, Peraire J, Arnedo M, Alcami J, Leal M, Villarroya F, Gatell JM: Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy. Expert Opin Drug Metab Toxicol. 2011, 7 (11): 1365-1382.CrossRefPubMed Vidal F, Domingo P, Vilades C, Peraire J, Arnedo M, Alcami J, Leal M, Villarroya F, Gatell JM: Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy. Expert Opin Drug Metab Toxicol. 2011, 7 (11): 1365-1382.CrossRefPubMed
54.
go back to reference Domingo P, Vidal F, Domingo JC, Veloso S, Sambeat MA, Torres F, Sirvent JJ, Vendrell J, Matias-Guiu X, Richart C, HIV-Frs Study Group: Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis. Eur J Clin Investig. 2005, 35 (12): 771-780.CrossRef Domingo P, Vidal F, Domingo JC, Veloso S, Sambeat MA, Torres F, Sirvent JJ, Vendrell J, Matias-Guiu X, Richart C, HIV-Frs Study Group: Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis. Eur J Clin Investig. 2005, 35 (12): 771-780.CrossRef
55.
go back to reference Yki-Jarvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A: Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol. 2003, 23 (4): 688-694.CrossRefPubMed Yki-Jarvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A: Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol. 2003, 23 (4): 688-694.CrossRefPubMed
56.
go back to reference Hadigan C, Meigs JB, Rabe J, D’Agostino RB, Wilson PW, Lipinska I, Tofler GH, Grinspoon SS: Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab. 2001, 86 (2): 939-943.CrossRefPubMed Hadigan C, Meigs JB, Rabe J, D’Agostino RB, Wilson PW, Lipinska I, Tofler GH, Grinspoon SS: Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab. 2001, 86 (2): 939-943.CrossRefPubMed
57.
go back to reference He G, Andersen O, Haugaard SB, Lihn AS, Pedersen SB, Madsbad S, Richelsen B: Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. Eur J Clin Invest. 2005, 35 (9): 583-590.CrossRefPubMed He G, Andersen O, Haugaard SB, Lihn AS, Pedersen SB, Madsbad S, Richelsen B: Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. Eur J Clin Invest. 2005, 35 (9): 583-590.CrossRefPubMed
58.
go back to reference Falasca K, Manigrasso MR, Racciatti D, Zingariello P, Dalessandro M, Ucciferri C, Mancino P, Marinopiccoli M, Petrarca C, Conti P, Pizzigallo E, Guagnano MT, Vecchiet J: Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. Ann Clin Lab Sci. 2006, 36 (1): 59-66.PubMed Falasca K, Manigrasso MR, Racciatti D, Zingariello P, Dalessandro M, Ucciferri C, Mancino P, Marinopiccoli M, Petrarca C, Conti P, Pizzigallo E, Guagnano MT, Vecchiet J: Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. Ann Clin Lab Sci. 2006, 36 (1): 59-66.PubMed
59.
go back to reference Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J, Grinspoon S: Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab. 2001, 86 (2): 504-510.PubMed Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J, Grinspoon S: Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab. 2001, 86 (2): 504-510.PubMed
Metadata
Title
Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome
Authors
Paula Freitas
Davide Carvalho
Ana Cristina Santos
António José Madureira
Esteban Martinez
Jorge Pereira
António Sarmento
José Luís Medina
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-347

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.